In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)

Steven J. McClue*, David Blake, Rosemary Clarke, Angela Cowan, Lorna Cummings, Peter M. Fischer, Mairi MacKenzie, Jean Melville, Kevin Stewart, Shudong Wang, Nikolai Zhelev, Daniella Zheleva, David P. Lane

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

310 Citations (Scopus)

Fingerprint Dive into the research topics of '<i>In vitro</i> and <i>in vivo</i> antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)'. Together they form a unique fingerprint.

Medicine & Life Sciences